Founding investors Arix and Atlas Venture led a Series A funding round and were joined by AbbVie Ventures and RA Capital, with $50 million providing enough cash to last around three years.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
A combination of these factors has led to the crowning of a new bisexual anthem: “Sweater Weather” by The Neighbourhood, a ...
There was good news on this score in 2017, with investment through vehicles that fund the sector including Arix Bioscience (£113 million) and Biopharma Credit (£606 million). The data in the ...
It was subsequently managed by Arix Capital Management following the acquisition of Arthurian by Arix Bioscience. One of the companies it invested in was ReNeuron which Sir Chris had been ...
It was subsequently managed by Arix Capital Management following the acquisition of Arthurian by Arix Bioscience. Last year ...
In November the trust made an all-share offer for biotech group Arix Bioscience. Arix has net assets of £232m, including £106m of cash, £56m in 15 listed but immature biotech investments ...